TIGIT Antibody / VSTM3 / VSIG9
TIGIT is a checkpoint inhibitor which binds with high affinity to the poliovirus receptor (PVR), causing increased IL10 secretion, decreased IL12B secretion. TIGIT binding to PVR also causes the suppression of T cell activation by promoting the generation of mature immuno-regulatory dendritic cells. It is expressed at low levels on natural killer (NK) cells, as well as peripheral memory and regulatory CD4+ T cells. At the protein level, it is upregulated following the activation of these cells. Functionally, TIGIT is similar to CTLA4. The ligands for TIGIT include CD155 (signal abrogation) and CD226 (signal stimulation) . It has been demonstrated to be upregulated on T cells in many cancers and is an immuno-oncology target for therapy.
Product Specifications
Specifications
ELISA
UniProt
Q495A1
Host
Mouse
Reactivity
Human
Immunogen
A portion of amino acids 22-141 from human TIGIT protein was used as the immunogen for the TIGIT antibody.
Clonality
Monoclonal
Isotype
IgG2c κ
Clone
TIGIT/3018
Applications
ELISA
Purity
Protein A/G affinity
Format
Purified
Limitations
This TIGIT antibody is available for research use only.
Storage Conditions
Aliquot the TIGIT antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
Formulation
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05% sodium azide
Applications Notes
Optimal dilution of the TIGIT antibody should be determined by the researcher.
Location
Cell membrane, Cell surface
Image Legend
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items